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Abstract
Background: A small, non-blinded, RCT (randomised controlled trial) had reported that oral
antibiotics reduced the incidence of mastitis in lactating women with Staphylococcus aureus (S.
aureus)- colonized cracked nipples. We aimed to replicate the study with a more rigorous design
and adequate sample size.
Methods: Our intention was to conduct a double-blind placebo-controlled trial to determine if an
antibiotic (flucloxacillin) could prevent mastitis in lactating women with S. aureus-colonized cracked
nipples. We planned to recruit two groups of 133 women with S. aureus-colonized cracked nipples.
Results: We spent over twelve months submitting applications to five hospital ethics committees
and seven funding bodies, before commencing the trial. Recruitment to the trial was very slow and
only ten women were randomized to the trial after twelve months, and therefore the trial was
stopped early.
Conclusions: In retrospect we should have conducted a feasibility study, which would have
revealed the low number of women in these Melbourne hospitals (maternity wards and
breastfeeding clinics) with damaged nipples. The appropriate use of antibiotics for breastfeeding
women with cracked nipples still needs to be tested.
Background
Mastitis is a common problem for breastfeeding women
[1,2]. Before planning a trial to reduce the number of lac-
tating women who develop mastitis, we reviewed the lit-
erature to identify factors that may be associated with
mastitis and to examine previous trials. A relatively small
number of trials was identified which included mastitis as
one of the outcome measures (see Table) [3-13]. Using
historical controls, prophylactic topical penicillin oint-
ment was found to be ineffective [3], while hand disinfect-
ant at the mother's bedside appeared to reduce mastitis
[7]. A Finnish study examined "breast massage" (which
appears to be a variation of "nipple toughening") and
found no impact of this practice on mastitis [10].
The authors of one trial were convinced that their inter-
vention was effective, despite methodological difficulties
[13,14]. Livingstone and Stringer conducted a ran-
domised trial for women with cracked nipples with posi-
tive cultures for Staphylococcus aureus (S. aureus), in
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Table 1: Trials to prevent mastitis
Author, date, 
country
Subjects Aim Control(presence/
absence/type)
Intervention Sample size Outcome: mastitis
Hesseltine et al 1948, 
USA[3]
Patients at the 
Chicago Lying-In 
Hospital: July – Sept 
1946
Does topical penicillin 
ointment on mother's 
nipples prevent mastitis?
Historical controls: July 
1933 to Dec 1946
Penicillin ointment (2,000 units per 
treatment) on nipples after feeds (6–8 
weeks)
Intervention 865; 
Controls 40,629
Intervention: 53 women 
with mastitis, 6.1%, and 18 
with abscess, 2%; Control: 
210 women with abscess, 
0.51%
Sasse 1973, Germany 
(in German)[4]
Postnatal women in 
the Frauenclinik der 
Freien Universitat 
Berlin-
Charlottenburg, 1967
Does an antibiotic spray 
to mother's nipples 
prevent mastitis?
Historical controls Nabectin Puder Spray(neomycin and 
bacitracin) applied to nipples, plus hand 
disinfection for nurses and mothers 
before handling breasts.
Intervention130; 
Controls100
Intervention: 7% mastitis 
by 2 months; Control: 
23%
Berger & Pusteria 1981 
Switzerland[5]
Postnatal women in 
the Women's 
Hospital, University of 
Berne(reported in 
1962 [22])
Does nipple ointment 
prevent mastitis?
One group used a 
nipple ointment 
without the active 
ingredient. Not a RCT.
Six nipple ointments:
(a) boric-acid Vaseline with Peruvian 
balsam,
(a) 1,000 (a) 1.5%
(b) chlortetracycline, (b) 1,000 (b) 0.7%
(c) chlorquinadol ointment, (c) 1,000 (c) 0.4%
(d) base of chlorquinadol ointment 
(without active ingredient),
(d) 1,000 (d) 0.4%
(e) calcium pantothenicum, (e) 2,000 (e) 0.8%
(f) dihydrofolliculin benzoate and 
tyrothrycin
(f) 1,500 (f) 0.5%
Kovalev 1990, Russia 
(in Russian)[6]
Does treating cracked 
nipples with laser 
therapy prevent mastitis?
Unclear from abstract Laser treatment to damaged nipples 329 women with 
damaged nipples
Intervention reduced 
mastitis from 18.6% to 
3.7%
Sytnik 1990, Russia [8] 
(in Russian)[8]
Does bifidobacterium 
prevent mastitis?
Unclear from abstract Bifidobacterium 160 women Mastitis reduced from 
6.88% to 1.25%
Peters and Flick-
Fillies1991, 
Germany[7,23]
Postnatal women in St 
Hildegardis Hospital, 
Mainz, 1989–1991
Does the use of bedside 
hand disinfectant prevent 
mastitis?
Historical controls: 12 
months (Sep 1989-Jun 
1990, May-Jun 1991)
Bed-side disinfectant dispensers: 12 
months (Jul 1990-April 1991, Jul-Aug 
1991)
Intervention: 1095; 
Control 1230
Intervention 8 women, 
0.65%; Control 32 women 
2.9%; p <0.001
Waldenstrom and 
Nilsson 1994, 
Sweden[9]
Women giving birth at 
South Hospital, 
Stockhom
Is birth centre care 
beneficial for 
breastfeeding? Does it 
increase duration and 
reduce complications 
(including mastitis)?
RCT Birth centre care compared to standard 
care
Intervention 617; 
Control 613.
Postal questionnaire 2 
months postpartum. "Milk 
stasis" (fever and swelling, 
redness and tenderness in 
one of the breasts): 
Intervention 26%; Control 
19% (p = 0.002). "Mastitis" 
(infective breast treated 
with antibiotics): 
Intervention 1%, Control 
< 1% (p = 0.07)
Jonsson & Pulkkinen 
1994, Finland[10]
Women in South-
West Finland
Does antenatal / 
postnatal breast massage 
prevent mastitis?
Concurrent controls. "Breast massage with the hands, a brush, 
a coarse towel or a sponge before and / 
or after delivery"
Intervention 255, 
Control 400.
Questionnaire 5–12 
weeks postpartum at 
outpatient visit. Overall 
incidence of mastitis was 
24%. No difference in 
incidence of mastitis (no 
details given). "This 
physical training of the 
nipples neither decreases 
or increases the 
frequency of mastitis" 
(p86)
Evans et al 1995, 
Australia[11]
Postnatal women at 
Flinders Medical 
Centre, Adelaide
Does prolonged feeding 
on one breast per feed 
reduce breastfeeding 
complications, including 
mastitis?
Historical controls: 5 
months
Advice to feed from one breast per feed 
and only offer the second breast if the 
baby still showed signs of hunger rather 
than standard care of both breasts at 
each feed: 5 months
Intervention 150; 
Control 152
Telephone interview at 6 
months postpartum: 
Intervention 15%; Control 
18%
Gunn et al 1998, 
Australia[12]
Women giving birth in 
one metropolitan 
hospital and one rural 
hospital in Victoria, 
1995
Does an early visit to a 
general practitioner 
reduce problems 
(including mastitis) 
compared to the 
standard six-week 
postnatal visit?
RCT General practitioner visit at one week 
compared to standard six week visit
Intervention 232; 
Control 243
Postal questionnaire at 3 
months. Intervention 
11.6%; Control 15.6% 
(Odds Ratio 0.71, 95%CI: 
0.42, 1.20)
Livingstone & Stringer, 
Canada[13]
Women attending the 
Vancouver 
Breastfeeding Center 
with a cracked nipple 
and S. aureus positive 
culture.
Are oral or topical 
antibiotics more effective 
in the treatment of S. 
aureus-colonized cracked 
nipples than standard 
care?
RCT (not blind to 
treatment group or 
outcome)
4 groups: Assessment at 7 days. 
Oral antibiotics: 1/19, 5%; 
Other groups: 16/65 
(25%) (Fisher exact 0.1)
(a) oral antibiotics (a) 19
(b) topical mupirocin (b) 25
(c) topical fusidic acid (c) 17
(d) standard care (d) 23BMC Pregnancy and Childbirth 2004, 4:19 http://www.biomedcentral.com/1471-2393/4/19
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Canada[13]. They compared topical antibiotics, oral anti-
biotics and "optimal breastfeeding advice" and found bet-
ter improvement in nipple healing in the women given
oral antibiotics. In addition, they found 16 women out of
65 (25%) given non-systemic treatment developed masti-
tis within 7 days, compared to 1 of 19 women (5%) given
systemic antibiotics (chi-square, p = 0.065) [not 0.005 as
stated in their abstract]. The authors have concluded that
cracked nipples colonized with S. aureus should be
"treated aggressively with systemic antibiotics". However,
the chi-square test used by the authors is inappropriate
because one cell contains an expected value less than 5.
Using Fisher's exact test, the p value is 0.10 [15].
As the Livingstone and Stringer trial had been published
in a major lactation journal and was likely to be very influ-
ential in practice [13], it needs to be replicated in a more
rigorous manner in order to assess the usefulness and
safety of the intervention. Our intention was to replicate
that study with an adequate sample size, rigorous defini-
tions of nipple damage and mastitis, and double blinding
of the intervention.
Methods
The aim of our study was to prevent mastitis in breastfeed-
ing women with cracked nipples colonized with S. aureus.
A randomised controlled trial was conducted: participat-
ing women were randomized to receive a seven day course
of either an oral antibiotic (flucloxacillin) or identical pla-
cebo capsules. A follow-up visit was arranged one week
after recruitment for women with positive nipple culture
for S. aureus. Women with negative nipple culture were
followed up by telephone at one week. All women
received a final telephone interview at six weeks.
The primary outcome was the incidence of mastitis in
each group in the week following recruitment. In the
study by Livingstone and Stringer [13] 30% of women
with  S. aureus-colonized cracked nipples who received
only breastfeeding advice developed mastitis within one
week. In order to detect a 50% decrease in incidence, ie
mastitis occurring in 15% of women receiving oral antibi-
otics, a sample size of 133 women in each group is
required, with 95% confidence and 80% power. Sample
size was calculated using Epi-Info 6.
A previous study in Australia found that 62% (13/21) of
cultures from breastfeeding women with cracked nipples
were positive for S. aureus [16]. An earlier study by Living-
stone and colleagues found that 54% of cracked nipples of
mothers with infants younger than one month were posi-
tive for S. aureus (27/50) [17]. Assuming that 50% of
cracked nipples are positive for S. aureus, we would need
133 × 2 × 2 = 532 women with cracked nipples, to recruit
two groups of 133 women with S. aureus-colonized
cracked nipples. To allow for loss to follow-up, it was
planned to recruit 570 women.
A review of the literature on the topic of nipple damage
found a lack of consistency in assessment of nipple dam-
age [18]. Many reports have not provided a clear descrip-
tion of the assessment process. Some of the more recent
studies have provided a more detailed description, such as
Brent et al's Nipple Attribute Score and Duffy et al's Nip-
ple Trauma Index [19,20]. The Nipple Trauma Index used
by Duffy and colleagues in Western Australia appeared to
be useful, however a request for more information about
this instrument was not successful (E. Duffy, email 28
February 2001) [20].
Our definitions of nipple damage are as follows: mild 1 or
2 mm wide; moderate 3–9 mm wide; severe: greater than
10 mm wide and / or yellow colour visible in crack. In
addition to a clinical assessment, a more permanent
record of nipple damage was created using digital photog-
raphy. It was planned for the photographs to be reviewed
independently by three lactation consultants, in order to
allow a thorough assessment of nipple damage and
changes over time, rather than relying on the clinical
assessment alone. (As the trial ended prematurely, this did
not take place).
Furthermore, although the WHO defines mastitis as an
inflammation of the breast [21], there is no generally
agreed definition of mastitis for research purposes. The
definition of mastitis used for this study was that a
woman reported:
• at least two breast symptoms (pain, redness, lump) and
• at least one of fever or 'flu-like symptoms.
Foreseen problems
Multi-centred trial
As we intended to recruit over 500 women we planned a
multi-centred trial, involving a number of public and pri-
vate maternity hospitals in inner Melbourne. All hospitals
provide a breastfeeding clinic staffed with International
Board Certified Lactation Consultants for women having
breastfeeding difficulties following hospital discharge.
The public hospitals, where women tend to have shorter
hospital stays, also provide home visits by domiciliary
midwives post discharge. It was foreseen that there would
be replication in the requirements of the hospital ethics
committees and logistical difficulties for one researcher
(LA) to conduct the study on multiple sites.
Each hospital had its own research ethics committee (or
committees) and different forms to submit (at the time of
this study). Approval was obtained from the EthicsBMC Pregnancy and Childbirth 2004, 4:19 http://www.biomedcentral.com/1471-2393/4/19
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Committees at La Trobe University (20/11/2000), Royal
Women's Hospital (6/9/2000), Mercy Hospital for
Women (12/2/2001), Frances Perry House (23/8/2001),
Freemasons Maternity Hospital (15/3/2001) and Cabrini
Private Hospital (24/04/02). One private hospital did not
appear to have a procedure in place to deal with a research
proposal. Negotiations continued with this hospital from
late 2000 until mid-2002 when the hospital insisted that
we sign a Sponsor Indemnity Form, which the university
advised us against.
The researcher visited the postnatal wards and breastfeed-
ing clinics of these hospitals each day or second day and
asked a senior member of the nursing staff if there were
any breastfeeding women with damaged nipples in the
ward. The staff member introduced the researcher to the
woman in order to inform the woman about the study
and invite her to participate in the trial. Also, the
researcher asked the domiciliary midwives to inform
women at home with a cracked nipple about the trial. If
the woman were interested in the study, the midwife gave
the researcher the woman's name and phone number.
After a telephone discussion, the researcher would visit
her at home to assess her eligibility.
Thus, the researcher was visiting a number of hospitals on
a daily basis and making home visits to potential partici-
pants and follow-up visits to participants one week after
recruitment. Therefore, if the researcher was going to be
unavailable one week, she could not recruit women the
week prior (as she would not be able to follow them up).
Funding
All potential participants had a specimen collected from
their nipple crack for culture and sensitivity. As this was
collected for the purpose of research rather than clinical
practice, it was necessary to seek funding for the cost of the
microbiological assessment. We intended to recruit 570
women, therefore substantial funds were required. A
number of applications (seven) were submitted to local,
national and international funding bodies in 2001. A
funding application to the Medical Research Foundation
for Women and Babies for 2002 was successful
(A$15,000).
Delay between recruitment and randomization
We recognized that there would be a delay between
recruitment (when the initial data and nipple specimen
were collected) and randomization (when the result was
available). The Microbiology laboratory faxed the result to
the researcher (or the researcher contacted the laboratory
on weekends). However, the minimum time was 2 days
for the laboratory to identify S. aureus and up to 6 days in
one instance (mean 3.6).
The delay meant that women would be at home when the
results were available and the researcher was required to
visit the participant at her home to deliver the capsules. In
addition to the inconvenience, a small number of women
had already developed mastitis by the time the researcher
contacted her with the result.
Unforeseen problems
Production of placebo capsules
It was expected that a local company specializing in the
preparation of placebos for drug trials would prepare the
identical capsules. A common practice is to cover the
active capsule with a larger capsule; participants are una-
ware if their capsule contains the active capsule or an inert
substance. However, when the company realized that the
active capsule contained a penicillin-like drug they were
unable to participate, as they do not have a license for
penicillin. Finally, the pharmaceutical company, CSL Ltd,
provided us with identical empty capsules as well as active
flucloxacillin capsules. A pharmacy technician at the phar-
macy department at the Royal Women's Hospital opened
each capsule manually and inserted glucose powder. Ran-
domisation was conducted in blocks of ten, stratified
according to hospital. Ten bottles were prepared for each
hospital prior to the trial commencing (further capsules
were not needed).
Participation
Not all the women who were eligible for the trial were
interested in taking part (see Figure 1, ROBIn Trial Pro-
file). Some women expressed a reluctance to take antibi-
otics, others were overwhelmed with the difficulties they
were experiencing and preferred not to participate in a
trial. The researchers had previously conducted studies
involving breastfeeding women which had high rates of
participation and had expected women to be more inter-
ested in taking part in a trial that aimed to prevent masti-
tis. We should have expected a lower participation rate as
this study involved the possibility of taking a medication,
in particular an antibiotic.
Less than anticipated incidence of cracked nipples
A total of approximately 17,000 women give birth in these
hospitals each year. We estimated that 80% of women
start breastfeeding, 5% develop cracked nipple(s), 80%
would be eligible and 95% would agree to participate,
thus there would be 537 eligible women per year. We
anticipated that we would recruit approximately ten
women with cracked nipples per week. It would therefore
take 57 weeks (57 × 10) to recruit the total sample.
However, recruitment was slow, as very few women were
identified with damaged nipples. Hospital staff made
unsolicited remarks that nipple damage was seen much
less frequently than in the past. Midwives have beenBMC Pregnancy and Childbirth 2004, 4:19 http://www.biomedcentral.com/1471-2393/4/19
Page 5 of 6
(page number not for citation purposes)
trained to help women position the baby and attach the
baby at the breast; women are reporting the presence of
nipple pain and any nipple damage is usually identified at
an early stage. In the past, women may have continued to
breastfeed with poor attachment of the baby to the breast,
resulting in more severe damage, whereas at the time of
the study maternity staff were likely to suggest "resting"
the damaged nipple and expressing the milk by hand or
electric pump until the damage had healed.
Results
Recruitment began at two hospitals in November 2001,
two others in February 2002 and a fifth hospital in June
2002. Recruitment was slow as few women had damaged
nipples. During the months of the trial, the rate of recruit-
ment decreased rather than increased. Additionally, the
flucloxacillin supplied by CSL were labeled to use before
the end of November 2002. Therefore it was decided to
stop recruiting, once a twelve-month recruiting period
had elapsed. The trial stopped recruiting on the 14th
November 2002.
Of the 158 women referred to the study as possible partic-
ipants, 48 women were eligible (ie they had a cracked nip-
ple, were not allergic to penicillin, did not have
concurrent "nipple thrush" and had adequate English).
Twenty-six of these women refused (10 not interested, 9
didn't want to take antibiotics, 7 other reason given).
Therefore, 22 were potentially eligible in that they had at
least one cracked nipple and consented to take part in the
trial if the results of the nipple swab confirmed S. aureus.
Thirteen of the nipple cultures were positive and ten
women were randomized to receive flucloxacillin (n = 5)
or placebo capsules (n = 5). Two women had already
developed mastitis prior to receiving the results and the
third woman had developed a rash and did not want to
take the capsules. All women were followed-up at one
week and six weeks. Of the ten women in the RCT, one
woman in the placebo group developed mastitis (not in
the first week of the trial, baby was 32 days old, 28 days
after randomization). Three women reported that they
had not taken the capsules. When the study was
unblinded it showed that all three were in the placebo
group.
Discussion
This trial experienced a number of problems, both fore-
seen and unforeseen. In the trial conducted by Living-
stone and Stringer, there is no mention of women refusing
to participate in the study or not taking the treatment they
were allocated [13]. It is not reported if any woman devel-
oped mastitis in the period between collection of the
swab, the clinician receiving the result and the woman
being given her allocated treatment regime – indeed the
paper does not state that women had to return to the
breastfeeding clinic for this. Possibly, women attending a
breastfeeding clinic are more likely to comply with treat-
ment regimes than women who are invited to participate
in a trial.
We thought the estimate of 5% of breastfeeding women
developing a cracked nipple was a conservative estimate.
For example, in Western Australia, Duffy et al had found
that 6% of women in their intervention group had cracked
nipples, compared to 69% in their control group [20].
However, on visiting the postnatal wards and breastfeed-
ing clinics in inner Melbourne, it was not unusual to find
that the staff were unable to identify any women with
damaged nipples. And of the women who were assessed,
more than half did not have a cracked nipple. Therefore,
nipple damage appears to be uncommon in breastfeeding
women in Melbourne.
Conclusions
In retrospect, we should have conducted a pilot or feasi-
bility study before commencing the trial. The appropriate
use of antibiotics for breastfeeding women with cracked
nipples still needs to be tested. We hope our experience
will be useful for others planning trials of mastitis or nip-
ple damage.
ROBIn Trial Profile Figure 1
ROBIn Trial Profile
Excluded (n =136) 
Not cracked (n = 71) 
Refused (n = 32) 
Not approached (n = 17) 
Ineligible (n = 16) 
Recruited (n = 22) 
Nipple S. aureus negative (n = 9)
Nipple S. aureus positive (n = 13) 
Randomised (n =10) 
Not randomised (n =3) 
Treated for mastitis before
randomization (n = 2) 
Had rash (n =1)
Flucloxacillin 7 days (n =5) 
Capsules taken (n =5) 
Placebo 7 days (n =5) 
Capsules taken (n =2) 
1 week follow up 
(n =5) 
1 week follow up 
(n =5) 
6 week follow up 
(n =5) 
6 week follow up 
(n =5) 
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